Zobrazeno 1 - 10
of 53
pro vyhledávání: '"153sm edtmp"'
Publikováno v:
Nuclear Medicine Communications. 42:951-963
Many human cancers predominantly metastasize to the bone which causes bone pain and other symptoms. However, the management of bone metastases is challenging. Radionuclide therapy using low-energy beta-emitting radionuclides has yielded encouraging r
Autor:
Zahra Azizmohammadi, Majid Assadi, Payman Dadkhah, Mehrdad Taheri, Rohollah Valizadeh, Mojtaba Ansari, Kasra Dehghan
Publikováno v:
Nuklearmedizin. 57:174-180
Introduction: Bone pain from multifocal blastic or mixed lytic-blastic metastatic lesions can be effectively addressed with radiopharmaceuticals with high affinity for such foci. 153Sm-ethylene diamine tetramethylene phosphonic acid (153Sm-EDTMP) and
The importance of BMI in dosimetry of 153 Sm-EDTMP bone pain palliation therapy: A Monte Carlo study
Publikováno v:
Applied Radiation and Isotopes. 124:1-6
Using digital phantoms as an atlas compared to acquiring CT data for internal radionuclide dosimetry decreases patient overall radiation dose and reduces the required analysis effort and time for organ segmentation. The drawback is that the phantom m
Autor:
Manisah Saedon, Muhammad Hanaffi Mohamad Mokhtar, Siti Hajar Ainee Kamzah, Rahimah Abdul Rahim, Azahari Kasbollah, Siti Selina Abdul Hamid, Noraisyah Mohd Yusof, Khong Khei Choong, Ng Yen, Mohd Rodzi Ali, Wan Hamirul Bahrin Wan Kamal
Publikováno v:
APPLICATION OF MATHEMATICS IN TECHNICAL AND NATURAL SCIENCES: 12th International On-line Conference for Promoting the Application of Mathematics in Technical and Natural Sciences - AMiTaNS’20.
Conventionally, metastatic cancer bone pain is managed by localized external radiotherapy and oral administration of analgesics. Due to the availability and cost, the use of bone-targeted radionuclide therapy in Malaysia has been restricted. The deve
Autor:
Monika Foroghy, Amir Reza Jalilian, Amir Hakimi, Simindokht Shirvani-Arani, Parandoush Abbasian
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 19(3):214-220
AimThe main purpose of this work was to develop a pharmacokinetic model for the bone pain palliation agent Samarium-153 ethylenediamine tetramethylene phosphonate ([153Sm]-EDTMP) in normal rats to analyze the behavior of the complex.BackgroundThe use
Publikováno v:
Frontiers in Medicine, Vol 4 (2017)
Frontiers in Medicine
Frontiers in Medicine
Introduction The aim of the present study was to compare the therapeutic efficacy of 153Sm-EDTMP and 177Lu-EDTMP in pain palliation in cancer patients with skeletal metastases. Materials and methods Thirty patients (25 M:5 F, mean age: 66.0 ± 14.7 y
Publikováno v:
Radiation Research. 173:386-391
To establish a basis for a possible strategy for bone marrow ablation or therapy, we examined the effect of bromodeoxyuridine (BrdU) incorporation into DNA on the genotoxic and cytotoxic effects of samarium-153 ethylenediaminetetramethylene phosphona
Publikováno v:
Health Physics. 98:537-541
Enhancements in radiation detection equipment at border crossings and airports resulted in a report to our institution from a Sm-EDTMP therapy patient who was questioned after triggering radiation alarms. Using a clinical SPECT camera in its service
Autor:
Carolyn J. Henry, Jeffrey N. Bryan, Jimmy C. Lattimer, Hendrik Engelbrecht, Dae Young Kim, Cathy S. Cutler, Margaret E. Bryan, David A. Bommarito, Linda M. Berent, Alan R. Ketring
Publikováno v:
Journal of Nuclear Medicine Technology. 37:45-52
Bone-seeking radiopharmaceuticals have been used to effectively treat cancer arising from and metastasizing to bone in humans and dogs. The rate of complete tumor control is low, and the geographic distribution of available compounds is limited by th
Autor:
Peter P. van Rijk, Marnix G.E.H. Lam, Bernard A. Zonnenberg, Wil Stevens, Amel Dahmane, John M. H. de Klerk
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 35:756-765
(153)Sm-ethylenediaminetetramethylenephosphonic acid (EDTMP; Quadramet) is indicated for the treatment of painful bone metastases, whereas zoledronic acid (Zometa) is indicated for the prevention of skeletal complications. Because of the different th